159 related articles for article (PubMed ID: 34171452)
1. Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities.
Leite ETT; Munhoz RR; Camargo VP; Lima LGCA; Rebolledo DCS; Maistro CEB; Busnardo FF; Ferreira FO; Salvajoli JV; Carvalho HA
Radiother Oncol; 2021 Aug; 161():222-229. PubMed ID: 34171452
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.
Guadagnolo BA; Bassett RL; Mitra D; Farooqi A; Hempel C; Dorber C; Willis T; Wang WL; Ratan R; Somaiah N; Benjamin RS; Torres KE; Hunt KK; Scally CP; Keung EZ; Satcher RL; Bird JE; Lin PP; Moon BS; Lewis VO; Roland CL; Bishop AJ
Lancet Oncol; 2022 Dec; 23(12):1547-1557. PubMed ID: 36343656
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
4. Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center.
Montero A; Chen-Zhao X; Ciérvide R; Álvarez B; Prado A; López M; Sánchez E; Hernando O; de la Casa MA; García-Aranda M; Valero J; Alonso R; Fernández-Letón P; Rubio C
Clin Transl Oncol; 2024 Jan; 26(1):204-213. PubMed ID: 37277526
[TBL] [Abstract][Full Text] [Related]
5. The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long-term community-based cancer center experience.
Kneisl JS; Ferguson C; Robinson M; Crimaldi A; Ahrens W; Symanowski J; Bates M; Ersek JL; Livingston M; Patt J; Kim ES
Cancer Med; 2017 Mar; 6(3):516-525. PubMed ID: 28188703
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial.
Gobo Silva ML; Lopes de Mello CA; Aguiar Junior S; D'Almeida Costa F; Stevanato Filho PR; Santoro Bezerra T; Nakagawa SA; Nascimento AG; Werneck da Cunha I; Spencer Sobreira Batista RM; Nicolau Daher UR; Da Cruz Formiga MN; Germano JN; Catin Kupper BE; De Assis Pellizzon AC; Lopes A
Radiother Oncol; 2021 Jun; 159():161-167. PubMed ID: 33798613
[TBL] [Abstract][Full Text] [Related]
7. [Complications and short-term outcomes of intraoperative electron radiotherapy (IOERT) in patients with periarticular soft-tissue sarcomas of the extremities].
Fan CC; Feng QF; Zhai YR; Li MH; Xu LB; Zhao ZG; Chen XY; Hu ZH; Zhang YQ; Yu SJ
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):311-5. PubMed ID: 22781047
[TBL] [Abstract][Full Text] [Related]
8. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
[TBL] [Abstract][Full Text] [Related]
9. Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Palma DA; Nguyen TK; Louie AV; Malthaner R; Fortin D; Rodrigues GB; Yaremko B; Laba J; Kwan K; Gaede S; Lee T; Ward A; Warner A; Inculet R
JAMA Oncol; 2019 May; 5(5):681-688. PubMed ID: 30789648
[TBL] [Abstract][Full Text] [Related]
10. Study of Preoperative Radiotherapy for Sarcomas of the Extremities with Intensity-Modulation, Image-Guidance and Small Safety-margins (PREMISS).
Röper B; Heinrich C; Kehl V; Rechl H; Specht K; Wörtler K; Töpfer A; Molls M; Kampfer S; von Eisenharth-Rothe R; Combs SE
BMC Cancer; 2015 Nov; 15():904. PubMed ID: 26573139
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Ablative Radiation Therapy for Large (≥5 cm) Non-small Cell Lung Carcinoma.
McDermott RL; Mihai A; Dunne M; Keys M; O'Sullivan S; Thirion P; ElBeltagi N; Armstrong JG
Clin Oncol (R Coll Radiol); 2021 May; 33(5):292-299. PubMed ID: 33309479
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS).
Cury FL; Viani GA; Gouveia AG; Freire CVS; Grisi GA; Moraes FY
Radiother Oncol; 2024 Jan; 190():109935. PubMed ID: 37884194
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Radiotherapy After Limb-sparing Surgery for Soft-tissue Sarcomas of the Distal Extremities.
Kim YJ; Song SY; Choi W; Je HU; Ahn JH; Chung HW; Lee JS
Anticancer Res; 2016 Sep; 36(9):4825-31. PubMed ID: 27630336
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
[TBL] [Abstract][Full Text] [Related]
15. Oligometastatic sarcoma treated with Curative intent Ablative Radiotherapy (OSCAR): A multicenter study on behalf of AIRO (Italian association of Radiotherapy and clinical Oncology).
Franceschini D; Greto D; Dicuonzo S; Navarria F; Federico M; La Vecchia M; Sangalli C; Allajbej A; Di Cristina L; Mazzola R; Pontoriero A; Montesi G; Navarria P; Baldaccini D; Clerici E; Lo Faro L; Franzese C; Di Biase S; Pergolizzi S; Alongi F; Bignardi M; Fazio I; Mascarin M; Jereczek-Fossa BA; Livi L; Scorsetti M
Radiother Oncol; 2024 Feb; 191():110078. PubMed ID: 38163485
[TBL] [Abstract][Full Text] [Related]
16. Preoperative stereotactic ablative body radiotherapy with postoperative conventional irradiation of soft tissue sarcomas: Protocol overview with a preliminary safety report.
Novikov SN; Gafton GI; Ebert MA; Fedosova EA; Melnik JS; Zinovev GV; Gafton IG; Sinyachkin MS; Kanaev SV
Radiother Oncol; 2021 Aug; 161():126-131. PubMed ID: 34089751
[TBL] [Abstract][Full Text] [Related]
17. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R
Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789
[TBL] [Abstract][Full Text] [Related]
18. Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic disease.
He K; Hong DS; Tang C; Sezen D; Cox L; Maleki A; Bertolet G; Nguyen QN; Comeaux NI; Schuda L; Chen D; Welsh JW
Radiother Oncol; 2023 Jun; 183():109618. PubMed ID: 36921766
[TBL] [Abstract][Full Text] [Related]
19. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
Roeder F; Lehner B; Schmitt T; Kasper B; Egerer G; Sedlaczek O; Grüllich C; Mechtersheimer G; Wuchter P; Hensley FW; Huber PE; Debus J; Bischof M
BMC Cancer; 2014 May; 14():350. PubMed ID: 24885755
[TBL] [Abstract][Full Text] [Related]
20. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
